IDO2 and neoplasm: As a tumor immunosuppressive mechanism, the surface expression of NKp46 on NK cells can be down-modulated by exposure to l-kynurenine, which is a tryptophan catabolism product generated by the indoleamine 2,3-dioxygenase (IDO) enzyme in tumor microenvironments (23).